Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Werewolf Therapeutics, Inc. (HOWL) had Income from Continuous Operations of $-17.98M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-17.98M |
|
-- |
|
-- |
|
$17.54M |
|
$-17.54M |
|
$-0.44M |
|
$-17.98M |
|
$-17.98M |
|
$-17.98M |
|
|
Income from Continuous Operations |
$-17.98M |
$-17.98M |
|
$-17.98M |
|
$-17.54M |
|
$-17.14M |
|
44.98M |
|
44.98M |
|
$-0.40 |
|
$-0.40 |
|
| Balance Sheet Financials | |
$80.44M |
|
$5.49M |
|
$12.13M |
|
$92.57M |
|
$15.17M |
|
$24.70M |
|
$35.93M |
|
$51.10M |
|
$41.46M |
|
$41.46M |
|
$41.46M |
|
45.34M |
|
| Cash Flow Statement Financials | |
$-34.11M |
|
$0.00M |
|
$0.39M |
|
$112.22M |
|
$78.49M |
|
$-33.72M |
|
$3.80M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.30 |
|
-- |
|
-- |
|
0.37 |
|
0.65 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-34.11M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-43.37% |
|
-43.37% |
|
-19.43% |
|
-27.18% |
|
$0.91 |
|
$-0.76 |
|
$-0.76 |
|